PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 52 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,498 | +17.1% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $9,818 | +63.4% | 150,000 | 0.0% | 0.00% | – |
| Q1 2023 | $6,008 | -99.6% | 150,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $1,540,545 | +1.8% | 150,000 | 0.0% | 0.05% | +32.4% |
| Q3 2022 | $1,514,000 | +0.7% | 150,000 | 0.0% | 0.04% | +5.7% |
| Q2 2022 | $1,503,000 | +0.1% | 150,000 | 0.0% | 0.04% | +2.9% |
| Q1 2022 | $1,501,000 | +0.9% | 150,000 | 0.0% | 0.03% | -12.8% |
| Q4 2021 | $1,487,000 | – | 150,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atalaya Capital Management LP | 225,000 | $15,750 | 0.02% |
| Q Global Advisors, LLC | 170,785 | $12 | 0.01% |
| MMCAP International Inc. SPC | 375,000 | $26,850 | 0.01% |
| PERISCOPE CAPITAL INC. | 957,098 | $68,528 | 0.01% |
| CVI Holdings, LLC | 44,106 | $3,158 | 0.01% |
| Silver Rock Financial LP | 12,224 | $875 | 0.01% |
| Castle Creek Arbitrage, LLC | 200,000 | $14,320 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 714,827 | $51,182 | 0.00% |
| Segantii Capital Management Ltd | 5,000 | $54,300 | 0.00% |
| GRITSTONE ASSET MANAGEMENT LLC | 17,014 | $1,218 | 0.00% |